Researchers have discovered that a long non-coding RNA called NORAD plays a crucial role in the health of endothelial cells, which line the inner walls of blood vessels. NORAD acts as a ‘sponge’ that binds to and regulates other molecules, including a microRNA called miR-106a and a key cell cycle regulator called CCND1. By modulating this network, NORAD helps maintain the integrity and function of endothelial cells, which is essential for preventing atherosclerosis – the buildup of fatty deposits in arteries that can lead to heart attacks and strokes. This new understanding of NORAD’s role in cardiovascular health could pave the way for novel therapies targeting this regulatory RNA.
Endothelial cells can become damaged or dysfunctional due to various factors, such as oxidative stress, inflammation, and exposure to harmful substances like oxidized LDL cholesterol. When this happens, it can set off a cascade of events that ultimately leads to the development of cardiovascular diseases like heart attacks and strokes.
The Regulatory Power of NORAD
Recent research has shed light on a fascinating molecule that helps maintain the health and function of endothelial cells: a long non-coding RNA called NORAD. Unlike typical protein-coding genes, long non-coding RNAs (lncRNAs) do not directly produce proteins but instead play critical regulatory roles in cells.
NORAD, which stands for Non-Coding RNA Activated by DNA damage, is a particularly intriguing lncRNA. As its name suggests, NORAD is activated in response to DNA damage and helps maintain the stability of chromosomes during cell division.
But NORAD’s influence extends far beyond chromosome stability. Researchers have now discovered that NORAD also plays a crucial role in regulating the behavior of endothelial cells, and thus the health of the cardiovascular system.
NORAD as a Molecular ‘Sponge’
The key to NORAD’s regulatory power lies in its ability to act as a ‘sponge’ for other molecules, including microRNAs (miRNAs) and messenger RNAs (mRNAs). MicroRNAs are small, non-coding RNA molecules that can bind to and suppress the expression of specific target genes. By sequestering these miRNAs, NORAD can indirectly influence the expression of their target genes.
In the case of endothelial cells, the researchers found that NORAD acts as a sponge for a microRNA called miR-106a. This miRNA has been shown to play a role in regulating cell proliferation and migration – two critical processes for maintaining healthy endothelial cells.
By binding to miR-106a, NORAD prevents it from targeting and suppressing the expression of a key cell cycle regulator called CCND1 (also known as Cyclin D1). CCND1 is essential for the proper progression of the cell cycle, allowing endothelial cells to proliferate and maintain their integrity.
Through this intricate regulatory network involving NORAD, miR-106a, and CCND1, the researchers found that NORAD helps promote the growth and survival of endothelial cells, ultimately protecting the cardiovascular system from the harmful effects of atherosclerosis.
Implications for Cardiovascular Health
The discovery of NORAD’s role in regulating endothelial cell function has important implications for our understanding and treatment of cardiovascular diseases. The researchers found that in patients with coronary artery disease, NORAD levels were significantly elevated in the bloodstream compared to healthy individuals.
This suggests that NORAD could potentially serve as a biomarker for the early detection of cardiovascular problems. By monitoring NORAD levels, healthcare providers may be able to identify individuals at risk of developing atherosclerosis or other heart-related conditions, allowing for early intervention and preventive measures.
Moreover, the researchers found that by silencing NORAD in endothelial cells, they were able to induce a process called ferroptosis – a form of programmed cell death driven by the accumulation of oxidative stress and disruption of cellular iron metabolism. This finding opens up the possibility of targeting NORAD as a potential therapeutic approach for cardiovascular diseases, potentially by mitigating the harmful effects of endothelial cell dysfunction and promoting their survival.
As the scientific community continues to unravel the complex regulatory networks governing cardiovascular health, the discovery of NORAD’s role represents an important step forward. By understanding how this versatile lncRNA helps maintain the integrity and function of endothelial cells, researchers may be able to develop new strategies for preventing and treating a wide range of heart-related conditions.
Author credit: This article is based on research by Tao He, Junxing Pu, Haijing Ge, Tianli Liu, Xintong Lv, Yu Zhang, Jia Cao, Hong Yu, Zhibing Lu, Fen Du.
For More Related Articles Click Here
